Nanotechnology a ‘white knight’ for drug development?

Author： Wright Tracey  

Publisher： Adis International

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.7, 2005-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics: pharmacogenie or pharmacogenerality in future drug discovery and development?

By D D.A.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 54-56

Adis International

Access to resources Recommend Favorite

Incentives for malaria vaccine development?

By  

Inpharma, Vol. 1, Iss. 1233, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Has Molecular and Cellular Imaging Enhanced Drug Discovery and Drug Development?

By Niu Gang   Chen Xiaoyuan  

Drugs in R&D, Vol. 9, Iss. 6, 2008-01 ,pp. : 351-368

Adis International

Access to resources Recommend Favorite

Economic Evaluations During Early (Phase II) Drug Development: A Role for Clinical Trial Simulations?

By Hughes D.A.   Walley T.  

PharmacoEconomics, Vol. 19, Iss. 11, 2001-11 ,pp. : 1069-1077

Adis International

Access to resources Recommend Favorite

Risperidone drug monitoring beneficial?

By  

Inpharma, Vol. 1, Iss. 1233, 2000-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite